X0407 4 2023-07-01 0 0001419041 Forte Biosciences, Inc. FBRX 0001339375 Riley Antony A C/O FORTE BIOSCIENCES, INC. 3060 PEGASUS PARK DR., BLDG 6 DALLAS TX 75247 0 1 0 0 Chief Financial Officer 0 Common Stock 2023-07-01 4 M 0 9375 0.00 A 28003 D Common Stock 2023-07-01 4 F 0 3241 1.04 D 24762 D Restricted Stock Units 2023-07-01 4 M 0 9375 0.00 D Common Stock 9375 131250 D Each restricted stock unit ("RSU") represents a contingent right to receive one share of Forte Biosciences, Inc. Common Stock. On July 1, 2023, the Reporting Person's RSUs vested. The closing price of Forte Biosciences, Inc.'s Common Stock on June 30, 2023 was the settlement price used to calculate the shares withheld. Subject to the Reporting Person continuing to be a Service Provider (as defined in the 2021 Equity Incentive Plan) through each applicable vesting date, one-sixteenth (1/16th) of the RSUs subject to the award shall vest on each Quarterly Vesting Date (as defined below) on or immediately following February 1, 2023. For purposes of this RSU Award, "Quarterly Vesting Date" with respect to any calendar year means January 1, April 1, July 1, and October 1. /s/ Paul A. Wagner, Ph.D., as Attorney-in-Fact 2023-07-05